A critical discovery in cancer study is emerging with the use of nanobodies to reactivate damaged p53. This crucial malignant inhibitor protein is frequently disabled in several types of tumors, causing uncontrolled https://bookmarkblast.com/story22046663/nanobodies-revive-tumor-suppressor-p53-new-potential-approach-for-tumor-management